| nr |
titel |
auteur |
tijdschrift |
jaar |
jaarg. |
afl. |
pagina('s) |
type |
| 1 |
A Review of Patient-Reported Outcomes Labeling for Oncology Drugs Approved by the FDA and the EMA (2012-2016)
|
Gnanasakthy, Ari
|
|
2019
|
22 |
2 |
p. 203-209
|
artikel
|
| 2 |
Assessing the Cost-Effectiveness of Updated Breast Cancer Screening Guidelines for Average-Risk Women
|
Tina Shih, Ya-Chen
|
|
2019
|
22 |
2 |
p. 185-193
|
artikel
|
| 3 |
Association between Disability, Cognition, Fatigue, EQ-5D-3L Domains, and Utilities Estimated with Different Western European Value Sets in Patients with Multiple Sclerosis
|
Eriksson, Jennifer
|
|
2019
|
22 |
2 |
p. 231-238
|
artikel
|
| 4 |
Comparison of Recommendations and Use of Cardiovascular Risk Equations by Health Technology Assessment Agencies and Clinical Guidelines
|
Betts, Marissa Blieden
|
|
2019
|
22 |
2 |
p. 210-219
|
artikel
|
| 5 |
Copyright/Subscription
|
|
|
2019
|
22 |
2 |
p. A3
|
artikel
|
| 6 |
Cost-Effectiveness of Alemtuzumab in the Treatment of Relapsing Forms of Multiple Sclerosis in the United States
|
Chirikov, Viktor
|
|
2019
|
22 |
2 |
p. 168-176
|
artikel
|
| 7 |
Cost Utility of Voretigene Neparvovec for Biallelic RPE65-Mediated Inherited Retinal Disease
|
Zimmermann, Marita
|
|
2019
|
22 |
2 |
p. 161-167
|
artikel
|
| 8 |
Economic Evaluation of Stem Cell Therapies in Neurological Diseases: A Systematic Review
|
Nagpal, Anjali
|
|
2019
|
22 |
2 |
p. 254-262
|
artikel
|
| 9 |
Editorial Board
|
|
|
2019
|
22 |
2 |
p. IFC
|
artikel
|
| 10 |
Equity Weights for Socioeconomic Position: Two Methods—Survey of Stated Preferences and Epidemiological Data
|
Lal, Anita
|
|
2019
|
22 |
2 |
p. 247-253
|
artikel
|
| 11 |
Estimating CHU-9D Utility Scores from the WAItE: A Mapping Algorithm for Economic Evaluation
|
Robinson, Tomos
|
|
2019
|
22 |
2 |
p. 239-246
|
artikel
|
| 12 |
Methods for Measuring Multiple Medication Adherence: A Systematic Review–Report of the ISPOR Medication Adherence and Persistence Special Interest Group
|
Pednekar, Priti P.
|
|
2019
|
22 |
2 |
p. 139-156
|
artikel
|
| 13 |
Paying Low-Income Smokers to Quit? The Cost-Effectiveness of Incentivizing Tobacco Quit Line Engagement for Medicaid Recipients Who Smoke
|
Mundt, Marlon P.
|
|
2019
|
22 |
2 |
p. 177-184
|
artikel
|
| 14 |
Perceptions of Response Burden Associated with Completion of Patient-Reported Outcome Assessments in Oncology
|
Atkinson, Thomas M.
|
|
2019
|
22 |
2 |
p. 225-230
|
artikel
|
| 15 |
Response to letter to the editor related to the retraction of a trial included in a meta-analysis of interventions to enhance oral medication adherence titled “Effectiveness and content analysis of interventions to enhance oral antidiabetic drug adherence in adults with type 2 diabetes: Systematic review and meta-analysis”
|
Vignon Zomahoun, Hervé Tchala
|
|
2019
|
22 |
2 |
p. 264-266
|
artikel
|
| 16 |
Table of Contents
|
|
|
2019
|
22 |
2 |
p. A1-A2
|
artikel
|
| 17 |
The Cost-Effectiveness of Financial Incentives for Viral Suppression: HPTN 065 Study
|
Adamson, Blythe
|
|
2019
|
22 |
2 |
p. 194-202
|
artikel
|
| 18 |
The Internal Validity of Discrete Choice Experiment Data: A Testing Tool for Quantitative Assessments
|
Johnson, F. Reed
|
|
2019
|
22 |
2 |
p. 157-160
|
artikel
|
| 19 |
The Retraction of a Trial Included in a Meta-Analysis of Interventions to Enhance Oral Medication Adherence
|
Gray, Richard
|
|
2019
|
22 |
2 |
p. 263-264
|
artikel
|
| 20 |
Was It Worth Introducing Health Economic Evaluation of Innovative Drugs in the French Regulatory Setting? The Case of New Hepatitis C Drugs
|
Clément, Valérie
|
|
2019
|
22 |
2 |
p. 220-224
|
artikel
|
Tijdschrift beschrijving